Tianjin Ringpu Bio Tech (300119) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.020x

Based on the latest financial reports, Tianjin Ringpu Bio Tech (300119) has a cash flow conversion efficiency ratio of 0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥105.02 Million ≈ $15.37 Million USD) by net assets (CN¥5.15 Billion ≈ $753.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 300119 company net worth for the company's overall valuation and market capitalisation.

Tianjin Ringpu Bio Tech - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Tianjin Ringpu Bio Tech's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tianjin Ringpu Bio Tech Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tianjin Ringpu Bio Tech ranked by their cash flow conversion efficiency. Explore Tianjin Ringpu Bio Tech cash earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Banpu Power Public Company Limited
BK:BPP
0.009x
Terveystalo Oy
HE:TTALO
0.057x
Bk Harda Internasional Tbk Pt
JK:BBHI
0.052x
Bombay Burmah Trading Corporation Limited
NSE:BBTC
0.039x
Chengdu Yunda Technology Co Ltd
SHE:300440
0.004x
COMPUGROUP MED.SP.ADR 1
F:COPA
N/A
Jaiprakash Power Ventures Limited
NSE:JPPOWER
0.082x
EFORT Intelligent Equipment Co Ltd
SHG:688165
-0.095x

Annual Cash Flow Conversion Efficiency for Tianjin Ringpu Bio Tech (2007–2025)

The table below shows the annual cash flow conversion efficiency of Tianjin Ringpu Bio Tech from 2007 to 2025. View today's stock price for Tianjin Ringpu Bio Tech for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥5.18 Billion
≈ $758.67 Million
CN¥297.53 Million
≈ $43.54 Million
0.057x -60.94%
2024-12-31 CN¥5.01 Billion
≈ $732.68 Million
CN¥735.55 Million
≈ $107.63 Million
0.147x +86.64%
2023-12-31 CN¥4.80 Billion
≈ $703.11 Million
CN¥378.20 Million
≈ $55.34 Million
0.079x -9.04%
2022-12-31 CN¥4.50 Billion
≈ $658.65 Million
CN¥389.49 Million
≈ $56.99 Million
0.087x -2.22%
2021-12-31 CN¥4.32 Billion
≈ $632.69 Million
CN¥382.63 Million
≈ $55.99 Million
0.088x -37.64%
2020-12-31 CN¥2.74 Billion
≈ $400.51 Million
CN¥388.44 Million
≈ $56.84 Million
0.142x -12.80%
2019-12-31 CN¥2.36 Billion
≈ $344.92 Million
CN¥383.61 Million
≈ $56.13 Million
0.163x +109.80%
2018-12-31 CN¥2.25 Billion
≈ $329.89 Million
CN¥174.88 Million
≈ $25.59 Million
0.078x +56.93%
2017-12-31 CN¥2.18 Billion
≈ $318.46 Million
CN¥107.57 Million
≈ $15.74 Million
0.049x -49.89%
2016-12-31 CN¥2.11 Billion
≈ $308.09 Million
CN¥207.67 Million
≈ $30.39 Million
0.099x -22.55%
2015-12-31 CN¥1.77 Billion
≈ $258.84 Million
CN¥225.27 Million
≈ $32.96 Million
0.127x +71.20%
2014-12-31 CN¥1.73 Billion
≈ $252.53 Million
CN¥128.37 Million
≈ $18.78 Million
0.074x +44.29%
2013-12-31 CN¥1.72 Billion
≈ $251.73 Million
CN¥88.68 Million
≈ $12.98 Million
0.052x -9.05%
2012-12-31 CN¥1.59 Billion
≈ $232.13 Million
CN¥89.92 Million
≈ $13.16 Million
0.057x -6.07%
2011-12-31 CN¥1.50 Billion
≈ $218.92 Million
CN¥90.29 Million
≈ $13.21 Million
0.060x -23.68%
2010-12-31 CN¥1.43 Billion
≈ $208.78 Million
CN¥112.82 Million
≈ $16.51 Million
0.079x -69.09%
2009-12-31 CN¥252.48 Million
≈ $36.95 Million
CN¥64.59 Million
≈ $9.45 Million
0.256x -6.06%
2008-12-31 CN¥249.97 Million
≈ $36.58 Million
CN¥68.07 Million
≈ $9.96 Million
0.272x +93.74%
2007-12-31 CN¥136.21 Million
≈ $19.93 Million
CN¥19.15 Million
≈ $2.80 Million
0.141x --

About Tianjin Ringpu Bio Tech

SHE:300119 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.14 Billion
CN¥7.79 Billion CNY
Market Cap Rank
#8363 Global
#1955 in China
Share Price
CN¥16.76
Change (1 day)
-3.01%
52-Week Range
CN¥14.38 - CN¥22.56
All Time High
CN¥39.94
About

Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, pharmaceutical preparation, functional additives, and veterinary biological products. The company provides vaccines, chemical drugs, traditional Chinese medicines; feed additives, including pigs, chickens, waterfowl, cattle, sheep and pet medicines, and vaccines; and p… Read more